Ariyeloye S, Watts D, Jaykar M, Ermis C, Kruger A, Kaden D
Cell Commun Signal. 2025; 23(1):86.
PMID: 39948619
PMC: 11827267.
DOI: 10.1186/s12964-025-02080-8.
Suri C, Swarnkar S, Bhaskar L, Verma H
Noncoding RNA. 2024; 10(5).
PMID: 39452836
PMC: 11514784.
DOI: 10.3390/ncrna10050050.
Toro A, Shukla S, Bansal P
Mol Biol Rep. 2023; 50(9):7681-7691.
PMID: 37418086
DOI: 10.1007/s11033-023-08586-z.
Zheng S, Xue T, Wang B, Guo H, Liu Q
Front Pharmacol. 2022; 13:926901.
PMID: 35991891
PMC: 9387999.
DOI: 10.3389/fphar.2022.926901.
Nikolova M, Naydenov M, Glogovitis I, Apostolov A, Saare M, Boggavarapu N
Life (Basel). 2021; 11(12).
PMID: 34947922
PMC: 8705090.
DOI: 10.3390/life11121391.
MicroRNA function can be reversed by altering target gene expression levels.
Svoronos A, Campbell S, Engelman D
iScience. 2021; 24(10):103208.
PMID: 34755085
PMC: 8560630.
DOI: 10.1016/j.isci.2021.103208.
Bcl-xL: A Focus on Melanoma Pathobiology.
Luciano A, Perez-Oliva A, Mulero V, Del Bufalo D
Int J Mol Sci. 2021; 22(5).
PMID: 33803452
PMC: 7967179.
DOI: 10.3390/ijms22052777.
MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review.
Morishita A, Oura K, Tadokoro T, Fujita K, Tani J, Masaki T
Cancers (Basel). 2021; 13(3).
PMID: 33572780
PMC: 7866004.
DOI: 10.3390/cancers13030514.
Perspectives of Molecular Therapy-Targeted Mitochondrial Fission in Hepatocellular Carcinoma.
Zhang H, Ye Y, Li W
Biomed Res Int. 2021; 2020:1039312.
PMID: 33457401
PMC: 7785342.
DOI: 10.1155/2020/1039312.
The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways.
Sartorius K, Swadling L, An P, Makarova J, Winkler C, Chuturgoon A
Viruses. 2020; 12(7).
PMID: 32664401
PMC: 7412373.
DOI: 10.3390/v12070746.
Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19.
Tao Q, Du J, Li X, Zeng J, Tan B, Xu J
Drug Dev Ind Pharm. 2020; 46(8):1345-1353.
PMID: 32643448
PMC: 7441778.
DOI: 10.1080/03639045.2020.1788070.
MicroRNAs in Animal Models of HCC.
Fornari F, Gramantieri L, Callegari E, Shankaraiah R, Piscaglia F, Negrini M
Cancers (Basel). 2019; 11(12).
PMID: 31805631
PMC: 6966618.
DOI: 10.3390/cancers11121906.
The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis.
Sartorius K, Makarova J, Sartorius B, An P, Winkler C, Chuturgoon A
Cells. 2019; 8(12).
PMID: 31771261
PMC: 6953055.
DOI: 10.3390/cells8121504.
Diagnostic Value of Circulating microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Jin X, Cai C, Qiu Y
J Cancer. 2019; 10(20):4754-4764.
PMID: 31598147
PMC: 6775527.
DOI: 10.7150/jca.32833.
Utilising network pharmacology to explore the underlying mechanism of Wumei Pill in treating pancreatic neoplasms.
Wan Y, Xu L, Liu Z, Yang M, Jiang X, Zhang Q
BMC Complement Altern Med. 2019; 19(1):158.
PMID: 31272505
PMC: 6611005.
DOI: 10.1186/s12906-019-2580-y.
miR-1-3p suppresses proliferation of hepatocellular carcinoma through targeting SOX9.
Zhang H, Zhang Z, Gao L, Qiao Z, Yu M, Yu B
Onco Targets Ther. 2019; 12:2149-2157.
PMID: 30962696
PMC: 6434909.
DOI: 10.2147/OTT.S197326.
Aging and aging-associated diseases: a microRNA-based endocrine regulation hypothesis.
Umansky S
Aging (Albany NY). 2018; 10(10):2557-2569.
PMID: 30375982
PMC: 6224249.
DOI: 10.18632/aging.101612.
Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma.
Sagnelli E, Potenza N, Onorato L, Sagnelli C, Coppola N, Russo A
World J Hepatol. 2018; 10(9):558-570.
PMID: 30310534
PMC: 6177563.
DOI: 10.4254/wjh.v10.i9.558.
MTP18 overexpression contributes to tumor growth and metastasis and associates with poor survival in hepatocellular carcinoma.
Zhang Y, Li H, Chang H, Du L, Hai J, Geng X
Cell Death Dis. 2018; 9(10):956.
PMID: 30237394
PMC: 6148245.
DOI: 10.1038/s41419-018-0987-x.
miR-1266-5p and miR-185-5p Promote Cell Apoptosis in Human Prostate Cancer Cell Lines.
Ostadrahimi S, Abedi Valugerdi M, Hassan M, Haddad G, Fayaz S, ParvizHamidi M
Asian Pac J Cancer Prev. 2018; 19(8):2305-2311.
PMID: 30141307
PMC: 6171381.
DOI: 10.22034/APJCP.2018.19.8.2305.